Literature DB >> 21221523

[Contribution of neurobiology to our knowledge of borderline personality disorder].

S C Herpertz1.   

Abstract

Affect dysregulation and impulsivity are the main topics of neurobiological research in borderline personality disorder. Affect dysregulation subsumes enhanced resting arousal, increased emotional responsiveness as well as deficient emotional regulation and is associated with structural and functional abnormalities in a prefrontal-limbic network, above all orbitofrontal hypoactivity and amygdalar as well as insular hyperactivity. Impulsivity describes a lack of future-oriented problem solving style as well as a decreased threshold for motoric responses and is associated with decreased serotonergic activity in the ventral prefrontal cortex. Future research has to clarify how specific the findings of borderline personality disorder are and how far temperament dimensions, such as neuroticism can explain the neurobiological deviations from the norm.

Entities:  

Mesh:

Year:  2011        PMID: 21221523     DOI: 10.1007/s00115-010-3127-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  43 in total

1.  Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study.

Authors:  S C Herpertz; T M Dietrich; B Wenning; T Krings; S G Erberich; K Willmes; A Thron; H Sass
Journal:  Biol Psychiatry       Date:  2001-08-15       Impact factor: 13.382

Review 2.  Volumes of the hippocampus and amygdala in patients with borderline personality disorder: a meta-analysis.

Authors:  Paulo Menezes Nunes; Amy Wenzel; Karinne Tavares Borges; Cristianne Ribeiro Porto; Renato Maiato Caminha; Irismar Reis de Oliveira
Journal:  J Pers Disord       Date:  2009-08

3.  Affective instability and impulsivity in personality disorder. Results of an experimental study.

Authors:  S Herpertz; A Gretzer; E M Steinmeyer; V Muehlbauer; A Schuerkens; H Sass
Journal:  J Affect Disord       Date:  1997-06       Impact factor: 4.839

4.  Dysregulation of regional endogenous opioid function in borderline personality disorder.

Authors:  Alan R Prossin; Tiffany M Love; Robert A Koeppe; Jon-Kar Zubieta; Kenneth R Silk
Journal:  Am J Psychiatry       Date:  2010-05-03       Impact factor: 18.112

5.  Emotional reactions to standardized stimuli in women with borderline personality disorder: stronger negative affect, but no differences in reactivity.

Authors:  Gitta A Jacob; Kathrin Hellstern; Nicole Ower; Mona Pillmann; Corinna N Scheel; Nicolas Rüsch; Klaus Lieb
Journal:  J Nerv Ment Dis       Date:  2009-11       Impact factor: 2.254

Review 6.  The cognitive control of emotion.

Authors:  Kevin N Ochsner; James J Gross
Journal:  Trends Cogn Sci       Date:  2005-05       Impact factor: 20.229

7.  Serotonin 2A receptor gene is associated with personality traits, but not to disorder, in patients with borderline personality disorder.

Authors:  Xingqun Ni; Ramprasad Bismil; Kirsten Chan; Tricia Sicard; Natalie Bulgin; Shelley McMain; James L Kennedy
Journal:  Neurosci Lett       Date:  2006-09-26       Impact factor: 3.046

8.  Emotion identification and tension in female patients with borderline personality disorder.

Authors:  Sabine Wolff; Christian Stiglmayr; Hans Joachim Bretz; Claas-Hinrich Lammers; Anna Auckenthaler
Journal:  Br J Clin Psychol       Date:  2007-09

9.  Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation.

Authors:  Nelson H Donegan; Charles A Sanislow; Hilary P Blumberg; Robert K Fulbright; Cheryl Lacadie; Pawel Skudlarski; John C Gore; Ingrid R Olson; Thomas H McGlashan; Bruce E Wexler
Journal:  Biol Psychiatry       Date:  2003-12-01       Impact factor: 13.382

Review 10.  The neural basis of mentalizing.

Authors:  Chris D Frith; Uta Frith
Journal:  Neuron       Date:  2006-05-18       Impact factor: 17.173

View more
  1 in total

Review 1.  [Organic personality disorder: conceptual principles, clinical symptoms and treatment].

Authors:  F U Lang; M Dudeck; T Becker; M Jäger
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.